A 4Pi algorithm developed at Dalhousie University, Canada, and licensed exclusively to Brainlab, will support personalized treatment planning in the upcoming Brainlab Elements Cranial SRS software*.

Used during the trajectory-based treatment planning phase, 4Pi is designed to reduce radiation dose to organs at risk without compromising target coverage or treatment times.

“Incorporating the 4Pi algorithm into the next generation of Brainlab cranial radiosurgery software can further increase the precision and efficiency of the treatments we offer,” commented Stefan Vilsmeier?, President and CEO, Brainlab.

“From planning to delivery, we strive to optimize the entire radiosurgery process.”

Visit Brainlab booth #4071 and take part in the Novalis Circle Dinner Symposium on opening night at AAPM to discover the latest technologies and techniques in the treatment of primary and secondary brain tumors.

Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.

Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange.

Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.

Privately held since its formation in Munich, Germany in 1989, Brainlab has more than 11,000 systems installed in about 100 countries.

Brainlab employs 1,350 people in 19 offices worldwide, including 385 Research & Development engineers, who form a crucial part of the product development team.

*This product is not available for sale and will not be available until all applicable approvals have been obtained.